George Budwell
George Budwell, Ph.D., is a contributing Biotechnology and Technology Analyst at The Motley Fool, covering disruptive innovators in healthcare, defense, and artificial intelligence, and writing on portfolio theory, dividend stocks, and value investing. Prior to The Motley Fool, George was a freelance medical and science writer for various organizations, as well as an independent consultant for multiple life sciences-oriented hedge funds. In a former life, he was an evolutionary biologist, having completed two postdoctoral fellowships at Kyoto University and Illinois State University, respectively. He holds a Ph.D. in Evolutionary Biology from Tulane University and a B.S. (pre-med) from Loyola University. Fun fact: George is an avid golfer, nature enthusiast, and proud father of four.
Recent Articles by George Budwell

5 Top AI Stocks I'm Buying on the Dip

Is Joby Aviation Stock a Buy?

25 Top AI Stocks That Could Boost Your Portfolio

3 Tech Defense Stocks That Could Be the Next Palantir

2 Cutting-Edge AI Stocks I'm Buying on the Dip

Better Quantum Computing Stock: IonQ vs. Alphabet

Better Artificial Intelligence Stock: Nvidia vs. ASML

Why Archer Aviation Is My Top Stock Pick for 2025

2 Top AI Stocks I'm Buying on the Dip

3 Best AI Stocks to Buy in February
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.